Cellectis (CLLS) Revenue (2015 - 2026)

Cellectis' Revenue history runs 12 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• In Q1 2026, Revenue fell 45.78% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $70.4 million (up 27.19% YoY), while the FY2025 annual figure was $72.9 million, up 48.22% from the prior year.
• Revenue was $5.8 million for Q1 2026 at Cellectis, down from $12.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $35.2 million in Q3 2025 to a low of $139000.0 in Q1 2023.
• Historically, Revenue has averaged $8.8 million across 5 years, with a median of $5.8 million in 2026.
• The sharpest annual moves came in 2023 and 2024: Revenue sank 98.23% in 2023, then surged 10351.61% in 2024.
• A 5-year view of Revenue shows it stood at $16.0 million in 2022, then tumbled by 98.23% to $283000.0 in 2023, then surged by 7118.37% to $20.4 million in 2024, then tumbled by 37.75% to $12.7 million in 2025, then slumped by 54.57% to $5.8 million in 2026.
• The last three Revenue figures came in at $5.8 million (Q1 2026), $12.7 million (Q4 2025), and $35.2 million (Q3 2025), per Business Quant data.